Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Journal articles
, 2014, 'Task shifting for non-communicable disease management in low and middle income countries - A systematic review', Plos One, 9, pp. e103754, http://dx.doi.org/10.1371/journal.pone.0103754
, 2014, 'A randomised controlled trial of a consumer-focused e-health strategy for cardiovascular risk management in primary care: The Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study protocol', BMJ Open, 4, pp. e004523, http://dx.doi.org/10.1136/bmjopen-2013-004523
, 2014, 'TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol', American Heart Journal, 167, pp. 127 - 132, http://dx.doi.org/10.1016/j.ahj.2013.10.020
, 2014, 'Use of a Multidrug Pill in Reducing Cardiovascular Events (UMPIRE): Rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe', European Journal of Preventive Cardiology, 21, pp. 252 - 261, http://dx.doi.org/10.1177/2047487312463278
, 2014, 'A multifaceted quality improvement intervention for CVD risk management in Australian primary healthcare: a protocol for a process evaluation', Implementation Science is, 9, pp. 187, http://dx.doi.org/10.1186/s13012-014-0187-8
, 2014, 'An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial', Medical Journal of Australia, 201, pp. 671 - 673, http://dx.doi.org/10.5694/mja14.00266
, 2014, 'Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial', Diabetes Care, 37, pp. 2202 - 2210, http://dx.doi.org/10.2337/dc13-2625
, 2014, 'Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: Results from the action in diabetes and vascular disease: Preterax and diamicron controlled evaluation (ADVANCE) trial', Hypertension, 63, pp. 259 - 264, http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.02252
, 2014, 'Hospital quality improvement initiative for patients with acute coronary syndromes in China a cluster randomized, controlled trial', Circulation Cardiovascular Quality and Outcomes, 7, pp. 217 - 226, http://dx.doi.org/10.1161/CIRCOUTCOMES.113.000526
, 2014, 'Intensification of medication and glycaemic control among patients with type 2 diabetes-The ADVANCE trial', Diabetes Obesity and Metabolism, 16, pp. 426 - 432, http://dx.doi.org/10.1111/dom.12238
, 2014, 'System barriers to the evidence-based care of acute coronary syndrome patients in China: Qualitative analysis', Circulation Cardiovascular Quality and Outcomes, 7, pp. 209 - 216, http://dx.doi.org/10.1161/CIRCOUTCOMES.113.000527
, 2014, 'The 'polypill' in the prevention of cardiovascular disease', Australian Prescriber, 37, pp. 82 - 86, http://dx.doi.org/10.18773/austprescr.2014.034
, 2014, 'The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes', Diabetes Care, 37, pp. 1353 - 1359, http://dx.doi.org/10.2337/dc13-2727
, 2014, 'Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial.', Am Heart J, 167, pp. 28 - 35, http://dx.doi.org/10.1016/j.ahj.2013.10.002
, 2014, 'Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial', DIABETES OBESITY & METABOLISM, 16, pp. 426 - 432, http://dx.doi.org/10.1111/dom.12238
, 2014, 'O105 Effect Of A Multi-Faceted Quality Improvement Intervention To Improve Cardiovascular Disease Risk Identification And Management In Australian Primary Health Care: The Torpedo Cluster-Randomised Trial', Global Heart, 9, pp. e28, http://dx.doi.org/10.1016/j.gheart.2014.03.1317
, 2014, 'PT253 Understanding the impact of a multifaceted quality improvement intervention to improve cardiovascular disease risk management in Australian Primary Health Care: The TORPEDO study process evaluation', Global Heart, 9, pp. e214 - e215, http://dx.doi.org/10.1016/j.gheart.2014.03.2002
, 2014, 'PW120 Does obesity increase risk in the patient with an ACS?', Global Heart, 9, pp. e284 - e284, http://dx.doi.org/10.1016/j.gheart.2014.03.2248
, 2014, 'PW203 Impact of pill burden on the effects of a polypill-based strategy on use of indicated medications in people with or at high risk of cardiovascular disease', Global Heart, 9, pp. e298 - e298, http://dx.doi.org/10.1016/j.gheart.2014.03.2303
, 2013, 'Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: The SPACE Collaboration', International Journal of Cardiology, 170, pp. 30 - 35, http://dx.doi.org/10.1016/j.ijcard.2013.10.007
, 2013, 'A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: Protocol for the SMARTHealth India cluster randomised controlled trial', Implementation Science, 8, pp. 137, http://dx.doi.org/10.1186/1748-5908-8-137
, 2013, 'Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial', Circulation, 128, pp. 1325 - 1334, http://dx.doi.org/10.1161/CIRCULATIONAHA.113.002717
, 2013, 'Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: The UMPIRE randomized clinical trial', JAMA, 310, pp. 918 - 929, http://dx.doi.org/10.1001/jama.2013.277064
, 2013, 'Industry-sponsored clinical trials in emerging markets: Time to review the terms of engagement', JAMA, 310, pp. 907 - 908, http://dx.doi.org/10.1001/jama.2013.276913
, 2013, 'Inflammatory markers and the risk of vascular complications and mortality in type 2 diabetes mellitus', European Heart Journal, 34, pp. p5169, http://dx.doi.org/10.1093/eurheartj/eht310.p5169
, 2013, 'The predictors of discharge without clopidogrel following admission with acute coronary syndrome in australia - the concordance registry', European Heart Journal, 34, pp. p236, http://dx.doi.org/10.1093/eurheartj/eht307.p236
, 2013, 'The effects of patient characteristics and geographical region on hospitalization in patients with type 2 diabetes', Diabetic Medicine, 30, pp. 918 - 925, http://dx.doi.org/10.1111/dme.12181
, 2013, 'The Design and Rationale of the Australian Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events (CONCORDANCE)', Heart Lung and Circulation, 22, pp. 533 - 541, http://dx.doi.org/10.1016/j.hlc.2012.12.013
, 2013, 'INterpreting the Processes of the UMPIRE Trial (INPUT): Protocol for a qualitative process evaluation study of a fixed-dose combination (FDC) strategy to improve adherence to cardiovascular medications', BMJ Open, 3, pp. e002313, http://dx.doi.org/10.1136/bmjopen-2012-002313
, 2013, 'Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial', Plos One, 8, http://dx.doi.org/10.1371/journal.pone.0055807
, 2013, 'Intensive glucose control improves kidney outcomes in patients with type 2 diabetes', Kidney International, 83, pp. 517 - 523, http://dx.doi.org/10.1038/ki.2012.401
, 2013, 'Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial', European Psychiatry, 28, pp. 49 - 52, http://dx.doi.org/10.1016/j.eurpsy.2011.07.005
, 2013, 'The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus', Diabetes Obesity and Metabolism, 15, pp. 1008 - 1012, http://dx.doi.org/10.1111/dom.12122
, 2013, 'The post hoc use of randomised controlled trials to explore drug associated cancer outcomes: Methodological challenges', Current Drug Safety, 8, pp. 371 - 378, http://dx.doi.org/10.2174/15748863113086660070
, 2013, 'Circulating Inflammatory Markers and The Risk of Vascular Complications and Mortality in People With Type 2 Diabetes Mellitus and Cardiovascular Disease or Risk Factors: The Advance Study', Diabetes, pp. DB_121625 - DB_121625
, 2013, 'Inflammatory Biomarker Levels and The Risk of Vascular Complications and Mortality in Type 2 Diabetes Mellitus', Heart, Lung and Circulation, 22, pp. S65 - S65
, 2013, 'The Predictors of Discharge Without Clopidogrel Following Admission with Acute Coronary Syndrome in Australia – The CONCORDANCE Registry', Heart Lung and Circulation, 22, pp. s51, http://dx.doi.org/10.1016/j.hlc.2013.05.122
, 2013, 'Validation of a general practice audit and data extraction tool.', Australian family physician, 42, pp. 816 - 819
, 2012, 'The Efficacy and Tolerability of 'Polypills': Meta-Analysis of Randomised Controlled Trials', Plos One, 7, pp. e52145, http://dx.doi.org/10.1371/journal.pone.0052145
, 2012, 'Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice', International Journal of Stroke, 7, pp. 649 - 654, http://dx.doi.org/10.1111/j.1747-4949.2011.00613.x
, 2012, 'Study protocol: Systematic review of the burden of heart failure in low- and middle-income countries', Systematic Reviews, 1, http://dx.doi.org/10.1186/2046-4053-1-59
, 2012, 'Effects of fibrates in kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, 60, pp. 2061 - 2071, http://dx.doi.org/10.1016/j.jacc.2012.07.049
, 2012, 'Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: Results of the advance study', Diabetes Care, 35, pp. 2201 - 2206, http://dx.doi.org/10.2337/dc12-0306
, 2012, 'Prediction of kidney-related outcomes in patients with type 2 diabetes', American Journal of Kidney Diseases, 60, pp. 770 - 778, http://dx.doi.org/10.1053/j.ajkd.2012.04.025
, 2012, 'Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes', Diabetes Research and Clinical Practice, 98, pp. 83 - 90, http://dx.doi.org/10.1016/j.diabres.2012.05.002
, 2012, 'Socio-economic distribution of cardiovascular risk factors and knowledge in rural India', International Journal of Epidemiology, 41, pp. 1302 - 1314, http://dx.doi.org/10.1093/ije/dyr226
, 2012, 'Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial', INTERNATIONAL JOURNAL OF STROKE, 7, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307882800038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'Global randomized trials: The promise of India and China', Journal of Bone and Joint Surgery, 94, pp. 92 - 96, http://dx.doi.org/10.2106/JBJS.L.00274
, 2012, 'Two decades of research on innovative models of care delivery for patients with heart failure: The end or just the beginning?', Archives of Iranian Medicine, 15, pp. 439 - 445
, 2012, 'Opinions of community pharmacists on the value of a cardiovascular polypill as a means of improving medication compliance', International Journal of Pharmacy Practice, 20, pp. 155 - 163, http://dx.doi.org/10.1111/j.2042-7174.2011.00175.x